Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Eleni Papakonstantinou (Thessaloniki, Greece), Eleni Papakonstantinou, Ioannis Klagas, Ioannis Bonovolias, George Karakiulakis, Michael Roth, Michael Tamm, Daiana Stolz. Glycosaminoglycans significantly correlate with matrix metalloproteinases during exacerbations of COPD. Eur Respir J 2015; 46: Suppl. 59, 5051

Member's Comments

No comment yet.

Related content which might interest you: Expression of matrix metalloproteinases in bronchoalveolar cells in COPD and in COPD phenotypes Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Pulmonary and systemic inflammation in patients with AECOPD Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014 Acute exacerbations in COPD patients are associated with increased levels of hyaluronic acid and heparan sulfate in BAL Source: International Congress 2014 – Translational studies in COPD Year: 2014 Role of matrix metalloproteinase in predicting of COPD stability Source: International Congress 2015 – COPD: notable points Year: 2015 MMP2, 8, 9 and TIMP1-4 levels in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease and bronchial asthma Source: Annual Congress 2010 - Mechanisms and modulation of allergic inflammation in the lung Year: 2010 Surfactant protein D and its oligomeric forms in chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Changes of TNF-a level in bronchoalveolar fluid of patients with chronic obstructive pulmonary disease before and after the 30 days treatment with tiotropium bromide Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects Year: 2015 Protective effects of tiotropium bromide on the morphological remodeling of the bronchi on the neocollagenesis processes in patients with moderate COPD during exacerbation Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Cellular composition of bronchoalveolar lavage (BAL) as inflammation indicator in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Diagnostic and therapeutic bronchoscopy: old and new techniques for interventional pulmonology Year: 2014 Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)? Source: Annual Congress 2011 - COPD mechanisms Year: 2011 Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007 The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases Year: 2009 HNP and CCSP protein levels are differentially regulated in BAL from patients with obstructive and restrictive chronic allograft dysfunctions Source: International Congress 2015 – Predictors of lung transplant complications Year: 2015 Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002 Effects of ageing and smoking on SP-A and SP-D levels in bronchoalveolar lavage fluid Source: Eur Respir J 2004; 24: 964-970 Year: 2004 Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001 Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019